Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction

American Heart Journal

Volumn 167, Issue 6, 2014, Pages 840-845

  Shen, Lan ^a,b   Shah, Bimal R ^a   Nam, Aro ^a   Holmes, Dajuanicia ^a   Alexander, Karen P ^a   Bhatt, Deepak L ^c   Ho, P Michael ^d   Peterson, Eric D ^a   He, Ben ^b   Roe, Matthew T ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; COMORBIDITY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; REGISTER; RISK; SECONDARY PREVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTICOAGULANTS; COHORT STUDIES; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FEMALE; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; REGISTRIES; RISK FACTORS; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84901761055     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.03.009     Document Type: Article

References (22)

1. N.S. Anavekar, J.J.V. McMurray, and E.J. Velazquez et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295 (Pubitemid 39258422)
2. M.T. Roe, A.Y. Chen, and C.P. Cannon et al. Temporal changes in the use of drug-eluting stents for patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) and Acute Coronary Treatment and Intervention Outcomes Network - Get With The Guidelines (ACTion-GWTG) registries Circ Cardiovasc Qual Outcomes 2 2009 414 420
3. A.A. Motivala, U. Tamhane, and V.S. Ramanath et al. A prior myocardial infarction: how does it affect management and outcomes in recurrent acute coronary syndromes? Clin Cardiol 31 2008 590 596
4. K.A. Eagle, M.J. Lim, and O.H. Dabbous et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2004 2727 2733 (Pubitemid 38725422)
5. D.A. Morrow, E.M. Antman, and A. Charlesworth et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
6. E.D. Peterson, M.T. Roe, and J.S. Rumsfeld et al. A call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction Circ Cardiovasc Qual Outcomes 2 2009 491 499
7. NCDR® ACTION Registry®-GWTG™ v2.2 coder's data dictionary National Cardiovascular Data Registry web site https://www.ncdr.com/WebNCDR/ docs/public-data-collection-documents/action-v2-codersdictionary-2-2.pdf?sfvrsn= 2 [Updated February 3, 2011. Accessed March 6, 2014]
8. S.L. Zeger, and K.Y. Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1986 121 130
9. C.T. Chin, A.Y. Chen, and T.Y. Wang et al. Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry - Get With The Guidelines (GWTG) acute myocardial infarction mortality model and risk score Am Heart J 161 2011 113 122.e2
10. R. Mathews, E.D. Peterson, and A.Y. Chen et al. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™ Am J Cardiol 107 2011 1136 1143
11. R.D. Lopes, E.D. Peterson, and A.Y. Chen et al. Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry JACC Cardiovasc Interv 3 2010 669 677
12. S.M. Haffner, S. Lehto, and T. Rönnemaa et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234 (Pubitemid 28350165)
13. K.P. Alexander, A.Y. Chen, and L.K. Newby et al. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative Circulation 114 2006 1380 1387 (Pubitemid 44462663)
14. D.L. Bhatt, M.T. Roe, and E.D. Peterson et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative JAMA 292 2004 2096 2104 (Pubitemid 39435100)
15. J.H. Alexander, R.D. Lopes, and S. James et al. Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
16. M.T. Roe, P.W. Armstrong, and K.A. Fox et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization N Engl J Med 367 2012 1297 1309
17. P. Tricoci, Z. Huang, and C. Held et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2012 20 33
18. J.L. Anderson, C.D. Adams, and E.M. Antman et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Circulation 116 2007 e148 e304
19. C.W. Hamm, J.P. Bassand, and S. Agewall et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
20. G. Montalescot, J. Dallongeville, and E. Van Belle et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry) Eur Heart J 28 2007 1409 1417 (Pubitemid 47343817)
21. M.T. Roe, L.S. Parsons, and C.V. Pollack Jr. et al. Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction Arch Int Med 165 2005 1630 1636 (Pubitemid 41124158)
22. K.A. Somma, D.L. Bhatt, and G.C. Fonarow et al. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction Circ Cardiovasc Qual Outcomes 5 2012 654 661